YILDIZ, F.; ÖKSÜZOĞLU, B. Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. Journal of Surgery and Medicine, [S. l.], v. 4, n. 6, p. 443–446, 2020. DOI: 10.28982/josam.745731. Disponível em: https://jsurgmed.com/article/view/745731. Acesso em: 25 apr. 2024.